Blood Clots

sanofi-aventis lauds new standards for prophylaxis of blood clots in surgical patients

Published in Medical Device Business Week, February 28th, 2007

sanofi-aventis applauded the National Quality Forum (NQF) performance measures aimed at reducing venous thromboembolism (VTE), or blood clots, in surgical patients. VTE is a serious complication after major surgery. It affects more than 900,000 Americans each year and claims up to 300,000 lives annually.

VTE includes deep vein thrombosis (DVT) and its complication, pulmonary embolism (PE). The NQF measures require hospitals to order appropriate prophylaxis for surgical patients and ensure that they receive prophylaxis within the 24 hours before to 24 hours after surgery.

"We have the knowledge and the proven therapies needed to reduce the risk of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Business Week

Source: Medical Device Business Week (2007-02-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry